Byooviz
NDC 82667-018, ranibizumab-nuna, injection, solution, from Harrow Eye, LLC.
- Product NDC
- 82667-018
- Status
- Listed
- Labeler
- Harrow Eye, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVITREAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761202
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82667-018 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RANIBIZUMAB10 mg/mL
Pharmacologic classes
Vascular Endothelial Growth Factor Inhibitor [EPC]; Vascular Endothelial Growth Factor Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82667-018-05 | 82667001805 | 1 VIAL, SINGLE-DOSE in 1 CARTON (82667-018-05) / .05 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/77b53b2c-da0e-44b2-ade4-b08ff75a7584Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=82667-018
Use it
Look up 82667-018 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82667-018 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82667-018. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.